Phase 2 Study of The Role of Pharmacologic Inhibition of TLR4 With E5564 on Glucose Metabolism in Insulin Resistant Subjects
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Eritoran (Primary)
- Indications Insulin resistance; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Eritoran2
- 06 Sep 2017 Status changed from recruiting to suspended.
- 15 Jan 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 22 Oct 2014 New trial record